KindlyMD unit commits $30 million in Metaplanet’s Bitcoin-focused equity raise
Quick Take Nakamoto said it has committed up to $30 million to participate in Metaplanet’s global equity offering. Nakamoto said the deal marks its largest single investment to date.
David Bailey's Nakamoto, a KindlyMD subsidiary, said it has committed up to $30 million to participate in Metaplanet's global equity offering, marking its largest investment to date and its first in an Asian public company with a bitcoin treasury strategy.
In a statement released Tuesday, Nakamoto said that the funding is scheduled to close on Sept. 16, with stock delivery expected the following day.
The investment comes as part of Metaplanet's international equity financing, with proceeds earmarked mainly for bitcoin purchases. Metaplanet said Tuesday it plans to issue 385 million new shares, raising about $1.4 billion to support its bitcoin accumulation strategy.
Metaplanet, listed on the Tokyo Stock Exchange, has positioned itself as Japan's first public company to adopt bitcoin as a primary treasury asset. On Monday, it disclosed the purchase of an additional 136 BTC for about $15.2 million, bringing its total holdings to 20,136 BTC and ranking it as the world's sixth-largest publicly traded corporate bitcoin holder.
KindlyMD's entry into bitcoin treasury operations stems from its August merger with Nakamoto Holdings, transforming the healthcare company into a dual-focused entity combining medical services with cryptocurrency investments.
KindlyMD's shares (NAKA) surged 77.2% on Nasdaq on Tuesday to close at $8.08, according to Google Finance data. Despite falling 43.4% over the past month, the stock remains up 551.6% year-to-date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Will the traditional Christmas rally still happen in the US stock market this year?
After a simultaneous technical and position-based recovery in the US stock market, Goldman Sachs, Morgan Stanley, and JPMorgan have successively signaled a year-end rebound. Extremely light positions, mean reversion of valuations, and seasonal support together create conditions for a short squeeze. However, global manufacturing import price inflation has annualized at around 24%, surpassing the pandemic peak, and the inflation bill will come due intensively in the first quarter of next year. Goldman Sachs warns that once the year-end rally materializes, it may exhaust future upside potential.
Anthropic IPO Roadshow: CEO Says "Doesn't Care About Market Conditions", Hopes to "Underpromise and Overdeliver"
As Anthropic gears up for its IPO, CEO Amodei remains deliberately low-key during the roadshow, emphasizing "under-promise and over-deliver," and appears calm regarding market volatility at the time of listing. In response to fluctuations in the AI sector and the Nvidia situation, Amodei stated he is not particularly concerned about the specific month of listing or market conditions, and frankly admits that allocation of computing power is "the most fundamental business challenge."
SpaceX (SPCX.US) Starship's 15th Test Flight: Booster recovery failed for unknown reasons; first orbital round-trip mission still awaits upper stage "tower catch" landing
On Friday local time, SpaceX conducted its 15th Starship flight mission in Texas.
Unlike Elon Musk’s “One Price” Approach: Anthropic (ANT.US) Roadshow Pricing Inquiry at $70-78, Institutional Investors Become the True Decision Makers in IPO Pricing
Anthropic will launch what is set to be the largest IPO in history next week, aiming to take this title from SpaceX. However, unlike Elon Musk’s conglomerate, large investors will have greater influence over its IPO pricing amid the ongoing turbulence in the artificial intelligence (AI) market.
Crypto prices
More
